Plozasiran: a small interfering RNA therapy for hypertriglyceridemia and familial chylomicronemia syndrome.

Rodriguez-Montes J, Hale G, Benny T

Open source

DOI
10.1007/s40199-026-00638-6
Published
2026 Aug 19
Container
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40199-026-00638-6,
  title = {Plozasiran: a small interfering RNA therapy for hypertriglyceridemia and familial chylomicronemia syndrome.},
  author = {Rodriguez-Montes J and Hale G and Benny T},
  year = {2026},
  journal = {Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences},
  doi = {10.1007/s40199-026-00638-6},
  url = {https://doi.org/10.1007/s40199-026-00638-6}
}

RIS

TY  - JOUR
TI  - Plozasiran: a small interfering RNA therapy for hypertriglyceridemia and familial chylomicronemia syndrome.
AU  - Rodriguez-Montes J
AU  - Hale G
AU  - Benny T
PY  - 2026
JO  - Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
DO  - 10.1007/s40199-026-00638-6
UR  - https://doi.org/10.1007/s40199-026-00638-6
ER  - 

APA

J, R., G, H., & T, B. (2026). Plozasiran: a small interfering RNA therapy for hypertriglyceridemia and familial chylomicronemia syndrome.. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences. https://doi.org/10.1007/s40199-026-00638-6

Source records